Saturday, Aug. 28, 2021 : Issue #1162

TOP STORIES - Diabetes News & Research

Youth Type 2 Diabetes Linked to a Higher Risk of Diabetes-Related Complications

ADA 81st Symposium: Are Point-Of-Care Devices Beneficial in Diagnosing Diabetic Neuropathy?

ADA 81st Symposium: The Combination of SGLT-2 inhibitors and GLP-1 Receptor Agonists

Letter from the Editor

I was talking to Ashley Ball, PharmD Candidate, LECOM-School of Pharmacy, about the problem with helping patients with DPN. We were talking about how you can definitively say the pain is really DPN, and not something else like arthritis.

She decided to see what kind of tests were available and how effective they are. Unlike glucose monitors, CGM devices, or even blood pressure monitors, there is no definitive device that clinicians can use.

She did put together a great feature on what is available and how you can take advantage of these tests for your patient.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief

Newsflash: US Preventive Services Task Force Issues New Screening Recommendation

The US Preventive Services Task Force released a final recommendation statement, published in the Journal of the American Medical Association, calling for prediabetes and type 2 diabetes screening for asymptomatic adults starting at 35 years of age for those that are overweight.

Did You Know? The Effects of Long-Term Drinking of Coffee:

The object of the study was to evaluate the long-term consequences of coffee drinking in patients with T2D and how it affects the risk of mortality from all-cause, CVD, and CHD. The researchers included ten prospective cohort studies with 82,270 cases. They found that compared to those with no coffee consumption, the HRs for 4 cups were 0.79, for all-cause mortality, 0,60, for CVD mortality, 0.68, for coronary heart disease (CHD) mortality, 0.72 for CHD, and 0.77 for total CVD events. Thus, the researchers concluded that "Drinking coffee can be inversely associated with the risk of mortality in patients with T2D." Nutrition, Metabolism & Cardiovascular Diseases (2021) 31, 2526-2538

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Ashley Ball, PharmD Candidate, LECOM-School of Pharmacy

Andy Dao, PharmD Candidate, University of South Florida Taneja College of Pharmacy

Jasmine Dumontier-Hiott, PharmD Candidate 2022, University of South Florida Taneja College of Pharmacy

Jerrine Fletcher, Doctor of Pharmacy Candidate, Florida A&M University College of Pharmacy and Pharmaceutical Sciences

Oluwatayo Ishola, PharmD. Candidate, South College, School of Pharmacy

Brenda Oppong, PharmD Candidate, LECOM School of Pharmacy

About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.

Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com

Diabetes In Control
2093 Philadelphia Pike #8370
Claymont, DE, 19703, United States

DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe

Saturday, Aug. 28, 2021 : Issue #1162

TOP STORIES - Diabetes News & Research

Newsflash: US Preventive Services Task Force Issues New Screening Recommendation

TOP STORIES - Diabetes News and Research

Did You Know? The Effects of Long-Term Drinking of Coffee:

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters: